MétaCan
Menu
← all works

RAD51B in Familial Breast Cancer

2016· article· en· 670 citations· W2345599686 on OpenAlex· 10.1371/journal.pone.0153788

Why is this work in the frame?

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Canadian funderA Canadian agency funded it. The work may carry no Canadian affiliation at all.

Full frame distilled prediction

Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

Candidate categories
none
Consensus categories
none
Domain
Candidate signal: noneConsensus signal: none
Study design
Candidate signal: Bench or experimentalConsensus signal: Bench or experimental
Genre
Candidate signal: EmpiricalConsensus signal: Empirical
Teacher disagreement score
0.055
Threshold uncertainty score
0.219
Validation status
machine_predicted_unvalidated · codex-gemma-dda1882f352a

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Opus teacher head0.022
GPT teacher head0.250
Teacher spread
0.227 · how far apart the two teachers sit on this one work
Validation status
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Abstract

Common variation on 14q24.1, close to RAD51B, has been associated with breast cancer: rs999737 and rs2588809 with the risk of female breast cancer and rs1314913 with the risk of male breast cancer. The aim of this study was to investigate the role of RAD51B variants in breast cancer predisposition, particularly in the context of familial breast cancer in Finland. We sequenced the coding region of RAD51B in 168 Finnish breast cancer patients from the Helsinki region for identification of possible recurrent founder mutations. In addition, we studied the known rs999737, rs2588809, and rs1314913 SNPs and RAD51B haplotypes in 44,791 breast cancer cases and 43,583 controls from 40 studies participating in the Breast Cancer Association Consortium (BCAC) that were genotyped on a custom chip (iCOGS). We identified one putatively pathogenic missense mutation c.541C>T among the Finnish cancer patients and subsequently genotyped the mutation in additional breast cancer cases (n = 5259) and population controls (n = 3586) from Finland and Belarus. No significant association with breast cancer risk was seen in the meta-analysis of the Finnish datasets or in the large BCAC dataset. The association with previously identified risk variants rs999737, rs2588809, and rs1314913 was replicated among all breast cancer cases and also among familial cases in the BCAC dataset. The most significant association was observed for the haplotype carrying the risk-alleles of all the three SNPs both among all cases (odds ratio (OR): 1.15, 95% confidence interval (CI): 1.11-1.19, P = 8.88 x 10-16) and among familial cases (OR: 1.24, 95% CI: 1.16-1.32, P = 6.19 x 10-11), compared to the haplotype with the respective protective alleles. Our results suggest that loss-of-function mutations in RAD51B are rare, but common variation at the RAD51B region is significantly associated with familial breast cancer risk.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

The record

Venue
PLoS ONE
Topic
BRCA gene mutations in cancer
Field
Biochemistry, Genetics and Molecular Biology
Canadian institutions
University of TorontoMount Sinai HospitalUniversité LavalLunenfeld-Tanenbaum Research InstituteCentre hospitalier universitaire de Québec
Funders
Medical Research and Materiel CommandNational Cancer InstituteCancer Council NSWNational Health and Medical Research CouncilMedical Research CouncilMinistero dello Sviluppo EconomicoDavid F. and Margaret T. Grohne Family FoundationNational Institutes of HealthCancer Council TasmaniaOrionin TutkimussäätiöCancer Institute NSWFonds Wetenschappelijk OnderzoekCanadian Institutes of Health ResearchAssociazione Italiana per la Ricerca sul CancroBiomedicum Helsinki-säätiöU.S. ArmyNorges ForskningsrådKreftforeningenCancer Research UKSuomen KulttuurirahastoFondation du cancer du sein du QuébecFrancis Crick InstituteCancer Council VictoriaDeutsche KrebshilfeMinisterio de Economía y CompetitividadAlfred Kordelinin SäätiöBundesministerium für Bildung und ForschungCancer Council South AustraliaDeutsches KrebsforschungszentrumEuropean CommissionBreast Cancer Research Foundation
Keywords
Breast cancerOdds ratioSingle-nucleotide polymorphismMedicineOncologyMale breast cancerHaplotypeCancerInternal medicineMissense mutationAlleleGeneticsMutationGenotypeBiologyGene
Has abstract in OpenAlex
yes